Oramed Pharmaceuticals Inc.
ORMP
Revenue
674.00k
▲8.00k▲1.20%
3 Months ChangeAssets
184.22M
▼-19.43M▼-9.54%
3 Months ChangeLiabilities
7.16M
▼-29.86M▼-80.66%
3 Months ChangeFree Cash Flow
-1.48M
▲4.27M▲74.29%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001213900-24-091795
2024-10-08
Form 8-K
ID: 0001213900-24-086214
2024-09-26
Form 8-K
ID: 0001213900-24-082237
2024-09-23
Form 8-K
ID: 0001213900-24-080812
2024-08-14
Form 10-Q
ID: 0001213900-24-068992
2024-08-02
Form 8-K
ID: 0001213900-24-064732
2024-06-26
Form 8-K
ID: 0001213900-24-055950
2024-06-24
Form 8-K
ID: 0001213900-24-055006
2024-06-10
Form 8-K
ID: 0001213900-24-051355
2024-05-13
Form 8-K
ID: 0001213900-24-041847